DMD and Duchenne muscular dystrophy: A single intravenous treatment of the mdx DMD mouse model with peptide-PMO (PPMO; designed to skip Dmd exon 23 and thereby rescue dystrophin expression) leads to restoration of ex-myomiRs toward wild-type levels.9